Security key
45256X103
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 68,558,924
- Total 13F value
- $255,147,599
- Share change
- +6,579,019
- Put/Call ratio
- 78%
- SEC-reported price per share
- $3.72
- Number of holders
- 172
- Value change
- +$21,750,911
- Number of buys
- 81
- Number of sells
- 68
- Shares outstanding
- 1,150,491,181
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
172
Top holders
10
IBRX full security history
Ownership snapshot
Full 13F holder table
ImmunityBio, Inc. SEC filings
ImmunityBio, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $87,416,951
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $87.42M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$87.42M
BlackRock Finance, Inc.
$72.19M
STATE STREET CORP
$49.7M
GEODE CAPITAL MANAGEMENT, LLC
$24.76M
JANE STREET GROUP, LLC
$10.85M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$87,416,951
13,831,796 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$72,193,924
11,423,089 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$49,700,809
7,864,052 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$24,763,179
3,917,494 shares
|
— | 30 Jun 2024 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
denominator unverified
|
$10,845,493
1,716,059 shares
|
— | 30 Jun 2024 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
Company
|
—
denominator unverified
|
$9,971,866
1,577,827 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
172
Shares
68,558,924
Rows available
172
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
188
Q3 2024 holders
172
Holder diff
-16
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|